DeutschNewstral
Article
Haaretz on 2015-12-01 00:26
The Ticker: Teva in Generic Tie-up With Japan’s Takeda
Related news
- The Ticker / Teva launches generic version of schizophrenia drug in U.S.Haaretz
- Business in Brief: India’s Dr. Reddy’s to Buy Eight Generic Drugs From Teva and AllerganHaaretz
- HTeva Revenue Loss Amid Generic Competitionhamodia.com
- FShire weighs fresh approach from Japan’s Takedaft.com
Japan’s Takeda Seeks to Expand Overseaswsj.com- The Ticker: Tiv Taam wins bidding for Eden Teva MarketHaaretz
- FJapan’s Takeda snaps up Ariad of the US for $5bnft.com
Shire shares rocket as Japan’s Takeda considers offerbizjournals.com- Shire Opens Door to $64 Billion Sale to Japan’s Takedawsj.com
- Japan’s Takeda Looks to More Acquisitions to Fuel Global Growthwsj.com
- The Ticker: Teva Shares Jump, IDE Buys Out Stake in Sorek Desalination PlantHaaretz
- Business in Brief: Teva to See Immediate Profits From Takeda Tie-upHaaretz
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bidReuters
Teva shares jump as drugmaker gets nod for generic version of allergy EpiPentimesofisrael.com
Teva to buy Allergan generic drug business for $40.5-billion, drops Mylan bidThe Globe and Mail- NOlympics: Japan’s Yamashita appointed chief as Takeda resigns in graft probenationalpost.com
Moderna says Japan’s Takeda plans to recall three lots of suspended COVID-19 vaccineThe Japan Times- The Ticker / Teva on hunt for a takeoverHaaretz